QualityStocksNewsBreaks Archives - Page 1184 of 1387

MondayNov 05, 2018 12:07 pm

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Driving Opportunities for Growth through Acquisitions

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) recently acquired HemPoland, increasing its opportunities for growth in the European market as part of the company’s international strategy. An article discussing the acquisition reads, “According to The Green Organic Dutchman CEO Brian Athaide, the transaction is a key milestone in the company’s long-term acquisition strategy. It delivers immediate revenue to shareholders while opening up a new vertical for the company. It also provides evidence of the company’s growth toward its goal of having operations in 12 countries on three continents by the end of…

MondayNov 05, 2018 11:37 am

QualityStocksNewsBreaks – American Premium Water Corp. (HIPH) Appoints CEO as Interim Chairman

American Premium Water (OTC: HIPH) this morning announced that CEO Ryan Fishoff has been appointed as Interim Chairman, effective November 2, 2018. “I am extremely honored to have the additional responsibility of Interim Chairman. When I was given the opportunity to take over as CEO last year, the board believed in my vision for this company. Over the past year I have been able to implement a lot of that vision, and I am looking forward for the upcoming year to continue to grow and achieve the goals that I have outlined as the company continues to transform and get…

MondayNov 05, 2018 10:43 am

QualityStocksNewsBreaks – Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) Increases Investment in Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

British Columbia-based fully-integrated cannabis company Choom Holdings (CSE: CHOO) (OTCQB: CHOOF), together with Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB), this morning announced that the companies have completed a non-brokered private placement of a debenture in the principal amount of $20,000,000 in Choom by Aurora, convertible into common shares of Choom at a conversion price of $1.25 per share, with a four year maturity date. The unsecured convertible debenture is subject to a minimum conversion amount of $5,000,000. Following the expiration of the hold period, if the volume weighted average trading price ("VWAP") of the common shares on the CSE…

MondayNov 05, 2018 10:02 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Increases Stake in RailVision after Substantial Technological and Commercial Advancements

Automotive technology innovator Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) this morning announced that it has increased its stake in RailVision Ltd. by exercising warrants into 2,704 ordinary RailVision shares for an aggregate of $0.6 million. The move follows last September’s InnoTrans International Trade Fair for Transport Technology in Berlin, where RailVision demonstrated substantial commercial and technological progress. As a result of the exercise, Foresight now holds 36.33 percent of RailVision’s issued and outstanding share capital, of which 33.78 percent is on a fully diluted basis. RailVision, a leading provider of cutting-edge safety systems and cognitive vision sensor technology…

MondayNov 05, 2018 9:39 am

QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) Submits IND Application, Protocol for Phase 1b/2 Clinical Trial with PRO 140

CytoDyn (OTCQB: CYDY) this morning announced its submission of an investigational new drug (“IND”) application to the U.S. Food and Drug Administration (“FDA”) to carry out a phase 1b/2 clinical trial with PRO 140 as a therapy for metastatic triple-negative breast cancer. Currently, limited therapeutic options are available for triple-negative breast cancer due to an absence of standard biomarkers for targeted options. The original research and issued patents on CCR5 as a therapeutic target for cancer treatment were led by Richard Pestell, M.D., Ph.D., CytoDyn’s Interim Chief Medical Officer. Dr. Pestell’s published conclusions verified that CCR5 is a crucial receptor…

FridayNov 02, 2018 3:21 pm

QualityStocksNewsBreaks – GreenBox POS, LLC (GRBX) Ensures Secure Payment through its Blockchain Powered QuickCard E-wallet

Hardware and software technology company GreenBox POS (OTC: GRBX) has developed its QuickCard e-wallet powered by blockchain that ensures secure payment. An article discussing the company reads, “The QuickCard mobile app, or consumer wallet, is a new way to use, interact and pay without money. After installing the app, consumers can load funds with a debit or credit card or at a QuickCard kiosk using cash. Funds loaded onto the wallet are available immediately for purchases at any location where QuickCard is accepted as a form of payment. The consumer wallet includes an easy-to-use interface through which consumers can purchase…

FridayNov 02, 2018 3:20 pm

QualityStocksNewsBreaks – First Cobalt Corp.’s (TSX.V: FCC) (OTCQX: FTSSF) Mineral Resource Estimate Results Bode Well for Iron Creek Project

Vertically integrated North American pure-play cobalt company First Cobalt (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC) recently reported the results of its first NI 43-101 Mineral Resource Estimate for its wholly-owned Iron Creek Cobalt Project in Idaho. FTSSF reported Inferred Mineral Resources of 29.6 million tons (26.9 million tonnes) grading 0.11 percent cobalt equivalent, under a base case scenario, and an alternative underground-only scenario indicating 4.9 million tons (4.4 million tonnes) grading 0.30 percent cobalt equivalent (http://ibn.fm/qqjG9). A recent article discussing the results reads, “An “Inferred Mineral Resource” is a concentration of some mineral that appears to have a reasonable prospect…

FridayNov 02, 2018 2:41 pm

QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Continues to Advance Promising BriaCell Clinical Program

During 2018, BriaCell Therapeutics (OTC: BCTXF) (TSX.V: BCT) has attained topline safety and efficacy clinical data in a clinical trial, achieved proof of concept and advanced its BriaCell clinical program. A recent article further discussing the important milestones the company has reached reads, “BriaCell recently announced excellent safety and efficacy data from a phase I/IIa proof of concept clinical study in advanced breast cancer patients. There were reports of tumor shrinkage in various sites. These results were confirming the findings from two previous proof-of-concept clinical trials that showed promising results in patients with advanced breast cancer. The most notable result…

FridayNov 02, 2018 12:20 pm

QualityStocksNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Receives Speculative Buy Rating, $5 Price Target from Clarus Securities

The Flowr Corporation (TSX.V: FLWR), a vertically integrated Canadian cannabis company headquartered in Markham, Ontario with a Kelowna, British Columbia-based production facility, is making a name for itself in the booming cannabis sector. FLWR was recently covered in a research report by Clarus Securities, which was then highlighted in a recent article published by CantechLetter.com, titled ‘The Flowr Corporation could be a big winner in the cannabis space, Clarus Securities says’. The research report describes the company as “one of the very few Canadian licensed producers of cannabis with experience in successfully scaling indoor cultivation of premium product.” Clarus Securities…

Site Search

Company Search

Category: QualityStocksNewsBreaks